Identification, Culture and Targeting of Cancer Stem Cells

Alejandro Herreros-Pomares1,2

  • 1Fundación de Investigación Hospital General Universitario de Valencia, 46014 Valencia, Spain.

Life (Basel, Switzerland)
|February 25, 2022
PubMed

Insights

Cancer stem cells (CSCs) drive tumor progression and chemoresistance. This review explores recent advances in identifying, cultivating, and targeting these cells for novel cancer therapies.

Area of Science:

  • Oncology
  • Stem Cell Biology

Background:

  • Cancer stem cells (CSCs) are implicated in chemoresistance, tumor progression, and metastasis.
  • Understanding CSCs is crucial for developing effective cancer therapies, yet many aspects remain unknown.
  • Dysregulation of stemness pathways (Notch, Wnt, Hedgehog) is linked to CSCs, necessitating further research for new therapeutic targets.

Purpose of the Study:

  • To review recent advancements in the identification, characterization, cultivation, and targeting of human CSCs.
  • To highlight progress in the clinical application of CSC-targeting therapies.
  • To identify areas requiring further research in CSC biology and therapy.

Main Methods:

  • Review of recent scientific literature on human cancer stem cells.
  • Analysis of studies focusing on CSC identification, characterization, and cultivation methods.
  • Examination of therapeutic strategies targeting CSCs and their clinical implementation.

Main Results:

  • Recent progress has been made in identifying and characterizing CSCs, though specific markers are still under development for many cancer types.
  • Cultivation methods for CSCs show heterogeneity, indicating an ongoing need for standardized protocols.
  • Advances in targeting CSCs show promise for clinical application, but further research is essential.

Conclusions:

  • Targeting cancer stem cells offers a promising avenue for future cancer treatment strategies.
  • Continued research is vital to overcome challenges in CSC identification, cultivation, and therapeutic targeting.
  • Translating CSC research into effective clinical therapies requires further investigation and development.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Distinctive Features of Adult Stem Cells vs Cancer Stem Cells01:18

Distinctive Features of Adult Stem Cells vs Cancer Stem Cells

A stem cell is an unspecialized cell that can divide without limit as needed and can, under specific conditions, differentiate into specialized cells.
Adult stem cells
Adult stem cells are tissue-specific; hence, they divide to develop the tissue from which they originate. One type of adult stem cell is the epithelial stem cell, which gives rise to the keratinocytes in the multiple layers of epithelial cells in the epidermis of the skin. Adult bone marrow has three distinct types of stem cells:...
3.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K